You've discovered something significant.

At Merck, we share your passion for developing breakthrough vaccines and medicines that advance human health. We are inspired by your discoveries and we want to work with you to bring your innovation from bench to bedside.

Favorable Licensing Candidates

We're interested in:

• Novel patented compounds
• Targets with proof of concept
• Molecules with a defined mechanism of action or testable hypothesis'
• Technologies with patent protection that provide a competitive advantage

Late-stage Opportunities: We will continue to pursue external licensing and partnership opportunities for differentiated products in all disease areas in late-stage development (Phase III-ready and later).

We are most interested in novel compounds that have large market potential for unmet medical needs. An attractive compound would have selectivity, potency, a demonstrated mechanism of action, preliminary toxicology data, oral availability, and a good half-life for once-daily administration. We also look for strong intellectual property protection on the target and the molecule.

Sending a proposal:
When contacting us about your discovery, we ask that you:

• Provide a clear, concise, non-confidential data package for review
• Highlight the advantages of your discovery
• Provide perspective on its value within the competitive landscape

Keep in mind that our review process is centralized and includes review by the appropriate experts from basic biology, chemistry, preclinical, clinical, marketing and patent.

We look forward to hearing about your discovery. Together, we can transform cutting-edge science into medicines that address unmet medical needs.